Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pe-diatric patients is 10-15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age-and gender-dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alter-ations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value.

Colopi, A., Fuda, S., Santi, S., Onorato, A., Cesarini, V., Salvati, M., et al. (2023). Impact of age and gender on glioblastoma onset, progression, and management [10.1016/j.mad.2023.111801].

Impact of age and gender on glioblastoma onset, progression, and management

Balistreri, Carmela Rita
Penultimo
Conceptualization
;
2023-04-01

Abstract

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, while its frequency in pe-diatric patients is 10-15%. For this reason, age is considered one of the major risk factors for the development of GBM, as it correlates with cellular aging phenomena involving glial cells and favoring the process of tumor transformation. Gender differences have been also identified, as the incidence of GBM is higher in males than in females, coupled with a worse outcome. In this review, we analyze age-and gender-dependent differences in GBM onset, mutational landscape, clinical manifestations, and survival, according to the literature of the last 20 years, focusing on the major risk factors involved in tumor development and on the mutations and gene alter-ations most frequently found in adult vs young patients and in males vs females. We then highlight the impact of age and gender on clinical manifestations and tumor localization and their involvement in the time of diagnosis and in determining the tumor prognostic value.
apr-2023
Colopi, A., Fuda, S., Santi, S., Onorato, A., Cesarini, V., Salvati, M., et al. (2023). Impact of age and gender on glioblastoma onset, progression, and management [10.1016/j.mad.2023.111801].
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0047637423000271-main 13.07.23.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 937.54 kB
Formato Adobe PDF
937.54 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/600875
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 12
social impact